Genitourinary. postprocedural disorder of genitourinary system, unspecified
Conditions
Interventions
Intervention 1: Intervention group: The intervention group will receive 0.3 µg/kg of dexmedetomidine (DEX) diluted in normal saline, administered over 10 minutes during the final 20 minutes of the sur
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: Age between 50 to 90 ASA I &II BMI lower than 35
Exclusion criteria
Exclusion criteria: Uncontrolled systemic diseases (such as diabetes, hypertension, and heart disease) Addiction Allergy to DEX
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality score based on the Athens Insomnia Scale (AIS). Timepoint: Sleep quality score at 24 and 48 hours postoperatively. Method of measurement: The Athens Insomnia Scale (AIS).;Delirium score assessed using the Confusion Assessment Method (CAM). Timepoint: Delirium score at 24 and 48 hours postoperatively. Method of measurement: The Confusion Assessment Method (CAM).;Incidence of complications including bradycardia and hypotension, according to clinical findings. Timepoint: Assessment of bradycardia and hypotension at 0, 6, 12, and 24 hours after surgery. Method of measurement: Automated vital signs monitor. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadTaha Rahimipour
Yazd University of Medical Sciences
Outcome results
None listed